Literature DB >> 17713528

Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice.

Jeffrey M Welch1, Jing Lu, Ramona M Rodriguiz, Nicholas C Trotta, Joao Peca, Jin-Dong Ding, Catia Feliciano, Meng Chen, J Paige Adams, Jianhong Luo, Serena M Dudek, Richard J Weinberg, Nicole Calakos, William C Wetsel, Guoping Feng.   

Abstract

Obsessive-compulsive disorder (OCD) is an anxiety-spectrum disorder characterized by persistent intrusive thoughts (obsessions) and repetitive actions (compulsions). Dysfunction of cortico-striato-thalamo-cortical circuitry is implicated in OCD, although the underlying pathogenic mechanisms are unknown. SAP90/PSD95-associated protein 3 (SAPAP3; also known as DLGAP3) is a postsynaptic scaffolding protein at excitatory synapses that is highly expressed in the striatum. Here we show that mice with genetic deletion of Sapap3 exhibit increased anxiety and compulsive grooming behaviour leading to facial hair loss and skin lesions; both behaviours are alleviated by a selective serotonin reuptake inhibitor. Electrophysiological, structural and biochemical studies of Sapap3-mutant mice reveal defects in cortico-striatal synapses. Furthermore, lentiviral-mediated selective expression of Sapap3 in the striatum rescues the synaptic and behavioural defects of Sapap3-mutant mice. These findings demonstrate a critical role for SAPAP3 at cortico-striatal synapses and emphasize the importance of cortico-striatal circuitry in OCD-like behaviours.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713528      PMCID: PMC2442572          DOI: 10.1038/nature06104

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  47 in total

1.  Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q.

Authors:  Y Y Shugart; J Samuels; V L Willour; M A Grados; B D Greenberg; J A Knowles; J T McCracken; S L Rauch; D L Murphy; Y Wang; A Pinto; A J Fyer; J Piacentini; D L Pauls; B Cullen; J Page; S A Rasmussen; O J Bienvenu; R Hoehn-Saric; D Valle; K-Y Liang; M A Riddle; G Nestadt
Journal:  Mol Psychiatry       Date:  2006-06-06       Impact factor: 15.992

2.  Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene.

Authors:  Vladimir M Pogorelov; Ramona M Rodriguiz; Megan L Insco; Marc G Caron; William C Wetsel
Journal:  Neuropsychopharmacology       Date:  2005-10       Impact factor: 7.853

3.  Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models.

Authors:  Michelle Day; Zhongfeng Wang; Jun Ding; Xinhai An; Cali A Ingham; Andrew F Shering; David Wokosin; Ema Ilijic; Zhuoxin Sun; Allan R Sampson; Enrico Mugnaini; Ariel Y Deutch; Susan R Sesack; Gordon W Arbuthnott; D James Surmeier
Journal:  Nat Neurosci       Date:  2006-01-15       Impact factor: 24.884

Review 4.  Auxiliary subunits assist AMPA-type glutamate receptors.

Authors:  Roger A Nicoll; Susumu Tomita; David S Bredt
Journal:  Science       Date:  2006-03-03       Impact factor: 47.728

5.  Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice.

Authors:  Noelia V Weisstaub; Mingming Zhou; Alena Lira; Evelyn Lambe; Javier González-Maeso; Jean-Pierre Hornung; Etienne Sibille; Mark Underwood; Shigeyoshi Itohara; William T Dauer; Mark S Ansorge; Emanuela Morelli; J John Mann; Miklos Toth; George Aghajanian; Stuart C Sealfon; René Hen; Jay A Gingrich
Journal:  Science       Date:  2006-07-28       Impact factor: 47.728

6.  Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.

Authors:  Diane E Dickel; Jeremy Veenstra-VanderWeele; Nancy J Cox; Xiaolin Wu; Daniel J Fischer; Michelle Van Etten-Lee; Joseph A Himle; Bennett L Leventhal; Edwin H Cook; Gregory L Hanna
Journal:  Arch Gen Psychiatry       Date:  2006-07

7.  Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

Authors:  Paul Daniel Arnold; Tricia Sicard; Eliza Burroughs; Margaret A Richter; James L Kennedy
Journal:  Arch Gen Psychiatry       Date:  2006-07

Review 8.  D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.

Authors:  D James Surmeier; Jun Ding; Michelle Day; Zhongfeng Wang; Weixing Shen
Journal:  Trends Neurosci       Date:  2007-04-03       Impact factor: 13.837

9.  Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000.

Authors:  Albina R Torres; Martin J Prince; Paul E Bebbington; Dinesh Bhugra; Traolach S Brugha; Michael Farrell; Rachel Jenkins; Glyn Lewis; Howard Meltzer; Nicola Singleton
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

10.  Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models.

Authors:  Anatol C Kreitzer; Robert C Malenka
Journal:  Nature       Date:  2007-02-08       Impact factor: 49.962

View more
  296 in total

1.  Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization.

Authors:  Hansen Wang; Susan S Kim; Min Zhuo
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Social peers rescue autism-relevant sociability deficits in adolescent mice.

Authors:  Mu Yang; Kayla Perry; Michael D Weber; Adam M Katz; Jacqueline N Crawley
Journal:  Autism Res       Date:  2010-10-06       Impact factor: 5.216

3.  Sapap3 deletion causes mGluR5-dependent silencing of AMPAR synapses.

Authors:  Yehong Wan; Guoping Feng; Nicole Calakos
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

4.  Electron tomographic analysis of synaptic ultrastructure.

Authors:  Alain C Burette; Thomas Lesperance; John Crum; Maryann Martone; Niels Volkmann; Mark H Ellisman; Richard J Weinberg
Journal:  J Comp Neurol       Date:  2012-08-15       Impact factor: 3.215

5.  The learned safety paradigm as a mouse model for neuropsychiatric research.

Authors:  Daniela D Pollak; Francisco J Monje; Gert Lubec
Journal:  Nat Protoc       Date:  2010-04-29       Impact factor: 13.491

6.  Noradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchrony.

Authors:  Kafui Dzirasa; H Westley Phillips; Tatyana D Sotnikova; Ali Salahpour; Sunil Kumar; Raul R Gainetdinov; Marc G Caron; Miguel A L Nicolelis
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

7.  Functional histamine H3 and adenosine A2A receptor heteromers in recombinant cells and rat striatum.

Authors:  Ricardo Márquez-Gómez; Meridith T Robins; Citlaly Gutiérrez-Rodelo; Juan-Manuel Arias; Jesús-Alberto Olivares-Reyes; Richard M van Rijn; José-Antonio Arias-Montaño
Journal:  Pharmacol Res       Date:  2017-12-05       Impact factor: 7.658

Review 8.  Peromyscus maniculatus bairdii as a naturalistic mammalian model of obsessive-compulsive disorder: current status and future challenges.

Authors:  De Wet Wolmarans; Isabella M Scheepers; Dan J Stein; Brian H Harvey
Journal:  Metab Brain Dis       Date:  2017-12-06       Impact factor: 3.584

9.  Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes.

Authors:  Pablo R Moya; Nicholas H Dodman; Kiara R Timpano; Liza M Rubenstein; Zaker Rana; Ruby L Fried; Louis F Reichardt; Gary A Heiman; Jay A Tischfield; Robert A King; Marzena Galdzicka; Edward I Ginns; Jens R Wendland
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

10.  Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism.

Authors:  Sheryl S Moy; Natallia V Riddick; Viktoriya D Nikolova; Brian L Teng; Kara L Agster; Randal J Nonneman; Nancy B Young; Lorinda K Baker; Jessica J Nadler; James W Bodfish
Journal:  Behav Brain Res       Date:  2013-11-08       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.